Cargando…

Salvage surgery following immuno-chemo-radiotherapy for advanced non-small cell lung cancer

BACKGROUND: Salvage surgery following definitive radiotherapy or systemic treatment has become a feasible treatment option in selected patients with advanced initially unresectable non-small cell lung cancer. Recent clinical trials of neoadjuvant treatment have showed that surgery following immuno-c...

Descripción completa

Detalles Bibliográficos
Autores principales: Nawashiro, Ayako, Tanaka, Fumihiro, Taira, Akihiro, Shinohara, Shinji, Takenaka, Masaru, Kuroda, Koji, Shimajiri, Shohei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8782972/
https://www.ncbi.nlm.nih.gov/pubmed/35061129
http://dx.doi.org/10.1186/s40792-022-01371-3
_version_ 1784638423424827392
author Nawashiro, Ayako
Tanaka, Fumihiro
Taira, Akihiro
Shinohara, Shinji
Takenaka, Masaru
Kuroda, Koji
Shimajiri, Shohei
author_facet Nawashiro, Ayako
Tanaka, Fumihiro
Taira, Akihiro
Shinohara, Shinji
Takenaka, Masaru
Kuroda, Koji
Shimajiri, Shohei
author_sort Nawashiro, Ayako
collection PubMed
description BACKGROUND: Salvage surgery following definitive radiotherapy or systemic treatment has become a feasible treatment option in selected patients with advanced initially unresectable non-small cell lung cancer. Recent clinical trials of neoadjuvant treatment have showed that surgery following immuno-chemotherapy is safely performed. Here, we present the first case of salvage surgery following immuno-chemotherapy with concurrent definitive radiotherapy for advanced lung large cell carcinoma. CASE PRESENTATION: A 44-year male was admitted to our hospital for salvage surgery. Ten months prior to this administration, he had been diagnosed with unresectable large cell carcinoma with malignant pericardial effusion (clinical stage IVA/T3N2M1A; no driver-gene alteration) originating from the right upper lobe (RUL). Due to rapid intrabronchial tumor growth causing severe dyspnea, emergency bronchial stenting in the right main bronchus using an expandable metallic stent had been performed. Thereafter, he had received immuno-chemotherapy with concurrent definitive radiotherapy. Despite dramatic radiographic response, he had suffered from persistent and refractory Pseudomonas aeruginosa lung infection associated with bronchial stent placement. As pericardial effusion had disappeared and no distant metastasis had developed, he was diagnosed with a potentially curable disease and was referred to our hospital. An extended sleeve resection was successfully performed, and pathological sections revealed that pathologic complete response was achieved with immuno-chemo-radiotherapy. The patient received no subsequent treatment, and is alive without tumor recurrence at 8 months after surgery. CONCLUSIONS: Salvage surgery following immuno-chemotherapy with concurrent definitive radiotherapy for advanced non-small cell lung cancer may be feasible in selected patients, and may be considered as a treatment option to control local disease. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40792-022-01371-3.
format Online
Article
Text
id pubmed-8782972
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-87829722022-02-02 Salvage surgery following immuno-chemo-radiotherapy for advanced non-small cell lung cancer Nawashiro, Ayako Tanaka, Fumihiro Taira, Akihiro Shinohara, Shinji Takenaka, Masaru Kuroda, Koji Shimajiri, Shohei Surg Case Rep Case Report BACKGROUND: Salvage surgery following definitive radiotherapy or systemic treatment has become a feasible treatment option in selected patients with advanced initially unresectable non-small cell lung cancer. Recent clinical trials of neoadjuvant treatment have showed that surgery following immuno-chemotherapy is safely performed. Here, we present the first case of salvage surgery following immuno-chemotherapy with concurrent definitive radiotherapy for advanced lung large cell carcinoma. CASE PRESENTATION: A 44-year male was admitted to our hospital for salvage surgery. Ten months prior to this administration, he had been diagnosed with unresectable large cell carcinoma with malignant pericardial effusion (clinical stage IVA/T3N2M1A; no driver-gene alteration) originating from the right upper lobe (RUL). Due to rapid intrabronchial tumor growth causing severe dyspnea, emergency bronchial stenting in the right main bronchus using an expandable metallic stent had been performed. Thereafter, he had received immuno-chemotherapy with concurrent definitive radiotherapy. Despite dramatic radiographic response, he had suffered from persistent and refractory Pseudomonas aeruginosa lung infection associated with bronchial stent placement. As pericardial effusion had disappeared and no distant metastasis had developed, he was diagnosed with a potentially curable disease and was referred to our hospital. An extended sleeve resection was successfully performed, and pathological sections revealed that pathologic complete response was achieved with immuno-chemo-radiotherapy. The patient received no subsequent treatment, and is alive without tumor recurrence at 8 months after surgery. CONCLUSIONS: Salvage surgery following immuno-chemotherapy with concurrent definitive radiotherapy for advanced non-small cell lung cancer may be feasible in selected patients, and may be considered as a treatment option to control local disease. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40792-022-01371-3. Springer Berlin Heidelberg 2022-01-21 /pmc/articles/PMC8782972/ /pubmed/35061129 http://dx.doi.org/10.1186/s40792-022-01371-3 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Case Report
Nawashiro, Ayako
Tanaka, Fumihiro
Taira, Akihiro
Shinohara, Shinji
Takenaka, Masaru
Kuroda, Koji
Shimajiri, Shohei
Salvage surgery following immuno-chemo-radiotherapy for advanced non-small cell lung cancer
title Salvage surgery following immuno-chemo-radiotherapy for advanced non-small cell lung cancer
title_full Salvage surgery following immuno-chemo-radiotherapy for advanced non-small cell lung cancer
title_fullStr Salvage surgery following immuno-chemo-radiotherapy for advanced non-small cell lung cancer
title_full_unstemmed Salvage surgery following immuno-chemo-radiotherapy for advanced non-small cell lung cancer
title_short Salvage surgery following immuno-chemo-radiotherapy for advanced non-small cell lung cancer
title_sort salvage surgery following immuno-chemo-radiotherapy for advanced non-small cell lung cancer
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8782972/
https://www.ncbi.nlm.nih.gov/pubmed/35061129
http://dx.doi.org/10.1186/s40792-022-01371-3
work_keys_str_mv AT nawashiroayako salvagesurgeryfollowingimmunochemoradiotherapyforadvancednonsmallcelllungcancer
AT tanakafumihiro salvagesurgeryfollowingimmunochemoradiotherapyforadvancednonsmallcelllungcancer
AT tairaakihiro salvagesurgeryfollowingimmunochemoradiotherapyforadvancednonsmallcelllungcancer
AT shinoharashinji salvagesurgeryfollowingimmunochemoradiotherapyforadvancednonsmallcelllungcancer
AT takenakamasaru salvagesurgeryfollowingimmunochemoradiotherapyforadvancednonsmallcelllungcancer
AT kurodakoji salvagesurgeryfollowingimmunochemoradiotherapyforadvancednonsmallcelllungcancer
AT shimajirishohei salvagesurgeryfollowingimmunochemoradiotherapyforadvancednonsmallcelllungcancer